Clinical Trials Browser

Phase 3 × INDUSTRY × gadobutrol × Clear all

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Phase 3 Completed

165 enrolled 24 charts

Brain Neoplasms

NCT01050829 2014-12-30

Gadobutrol Magnevist-controlled Body Study

Phase 3 Completed

Neoplasms

NCT01067976 2014-11-11

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI

Phase 3 Completed

446 enrolled 30 charts

Breast Neoplasms

NCT01104584 2014-11-11

GEMMA 2

Phase 3 Completed

460 enrolled 31 charts

Breast Neoplasms